Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.

UNLABELLED: BACKGROUND, PURPOSE AND METHODS: This observational study assessed the effect of continuous intraventricular infusion of pentosan polysulphate (PPS) in seven patients at different clinical centres in the UK. RESULTS: Complications of intraventricular catheterization were frequent. PPS w...

Full description

Bibliographic Details
Main Authors: Bone, I, Belton, L, Walker, A, Darbyshire, J
Format: Journal article
Language:English
Published: 2008
_version_ 1797063919310733312
author Bone, I
Belton, L
Walker, A
Darbyshire, J
author_facet Bone, I
Belton, L
Walker, A
Darbyshire, J
author_sort Bone, I
collection OXFORD
description UNLABELLED: BACKGROUND, PURPOSE AND METHODS: This observational study assessed the effect of continuous intraventricular infusion of pentosan polysulphate (PPS) in seven patients at different clinical centres in the UK. RESULTS: Complications of intraventricular catheterization were frequent. PPS was well-tolerated over a wide dose range (11-110 microg/kg/day) during the 6-month study. Four patients were assessed for the entire study period: one remained stable, two showed minimal deterioration and one progressed significantly. CONCLUSION: Mean survival of all patients was longer than reported values for natural history of specific prion disorders. Possible reasons for these findings are explored.
first_indexed 2024-03-06T21:06:51Z
format Journal article
id oxford-uuid:3cc3f19f-4f34-4243-a1c3-02e3213b82ca
institution University of Oxford
language English
last_indexed 2024-03-06T21:06:51Z
publishDate 2008
record_format dspace
spelling oxford-uuid:3cc3f19f-4f34-4243-a1c3-02e3213b82ca2022-03-26T14:15:32ZIntraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3cc3f19f-4f34-4243-a1c3-02e3213b82caEnglishSymplectic Elements at Oxford2008Bone, IBelton, LWalker, ADarbyshire, J UNLABELLED: BACKGROUND, PURPOSE AND METHODS: This observational study assessed the effect of continuous intraventricular infusion of pentosan polysulphate (PPS) in seven patients at different clinical centres in the UK. RESULTS: Complications of intraventricular catheterization were frequent. PPS was well-tolerated over a wide dose range (11-110 microg/kg/day) during the 6-month study. Four patients were assessed for the entire study period: one remained stable, two showed minimal deterioration and one progressed significantly. CONCLUSION: Mean survival of all patients was longer than reported values for natural history of specific prion disorders. Possible reasons for these findings are explored.
spellingShingle Bone, I
Belton, L
Walker, A
Darbyshire, J
Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.
title Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.
title_full Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.
title_fullStr Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.
title_full_unstemmed Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.
title_short Intraventricular pentosan polysulphate in human prion diseases: an observational study in the UK.
title_sort intraventricular pentosan polysulphate in human prion diseases an observational study in the uk
work_keys_str_mv AT bonei intraventricularpentosanpolysulphateinhumanpriondiseasesanobservationalstudyintheuk
AT beltonl intraventricularpentosanpolysulphateinhumanpriondiseasesanobservationalstudyintheuk
AT walkera intraventricularpentosanpolysulphateinhumanpriondiseasesanobservationalstudyintheuk
AT darbyshirej intraventricularpentosanpolysulphateinhumanpriondiseasesanobservationalstudyintheuk